| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.12 | 0.02 |